Lapatinib (base)

• Background:

  Potent inhibitor of EGFR kinase (Ki=3 nM), Erb-2 kinase (Ki=13 nM) Erb-4 kinase (Ki=347 nM) 1. Clinically useful agent for treatment of breast cancer2-3. Cell permeable

• Conjugation:

  Unconjugated

• Buffer:

  Yellow solid

• Storage Conditions:

  -20°C